Navigation Links
Perot Systems Launches Website in Chinese to Support Expansion Into China
Date:7/7/2009

BEIJING, July 7 /PRNewswire/ -- Perot Systems Corporation (NYSE: PER) (www.perotsystems.com) today announced the launch of a Chinese-language website as part of the company's expanded presence into China's market for information technology (IT) and business-process services.

"Perot Systems is in the early stages of business development with China-based organizations, and we are grateful for the reception we have received from local leaders across the country," said David Miller, Perot Systems Managing Director for China. "The new website will help Chinese enterprises become acquainted with Perot Systems, learn about our extensive capabilities, and understand our strong values."

The website - www.perotsystems.cn - provides translations of the current Perot Systems corporate website. It also contains additional features that portray the company's value proposition to the Chinese market.

Perot Systems creates and delivers IT and business-process services that help organizations operate more effectively and efficiently. The company's core capabilities include the development, deployment, and management of IT applications, IT infrastructure, and business processes. Target vertical markets include healthcare and a variety of commercial industries.

About Perot Systems

Perot Systems is a worldwide provider of information technology services and business solutions. Through its flexible and collaborative approach, Perot Systems integrates expertise from across the company to deliver custom solutions that enable clients to accelerate growth, streamline operations and create new levels of customer value. Headquartered in Plano, Texas, Perot Systems reported 2
'/>"/>

SOURCE Perot Systems Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Video: Perot Systems Unveils Series of Healthcare Video Case Studies
2. Perot Systems Wins Over $119 Million CDC Contract
3. Perot Systems Webinar: An Industry Perspective on HIT Policy Committees Framework for Meaningful Use
4. VIDEO: Perot Systems Launches Xcelys(TM) for Revenue Cycle Management
5. Apria Healthcare Awards Technology Solutions Contract to Perot Systems
6. Perot Systems Releases ARRA Webcast Featuring Leading Analyst Firm
7. Perot Systems to Supply Revenue Cycle Solutions to Amerinet Members Nationwide
8. Perot Systems Announces Special Financing Options for Stimulus Plan Healthcare Technology Upgrades
9. The Christ Hospital Selects Perot Systems for Revenue Cycle Solutions
10. Doylestown Hospital and Perot Systems Successfully Implement Advanced MEDITECH 6.0 Platform
11. Dell and Perot Systems Announce Strategic Alliance to Provide Fully-Integrated Virtualized Healthcare Technology Solutions to Reduce Cost and Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2ARKRAY, Inc. Announces Partnership With scil animal care company for the SPOTCHEM(TM) EZ Analyzer 2AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 1AMA Grants New Category III CPT Code to Premier Hearts Multifunction CardioGram 28TM 29 28MCG 29 51426 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 1Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 2Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharmas Product Class 4717 3PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 1PR Whiz Belinda Foster Launches Michael Jacksons Nurse Cherilyn Lee on World Media Campaign 51425 2
Other Medicine Technology:Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 2Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 3Updated Study Results Reinforce Survival Benefit of Taxotere,(Docetaxel) for Men with Advanced, Hormone-Resistant Prostate,Cancer 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma, Inc. Summarizes Data Presented at the 2007 American,Society of Clinical Oncology (ASCO) Annual Meeting 10